Molecular medicine and cancer

Heather M Wallace, Paul J Hergenrother, Peter J Sadler

Research output: Contribution to journalEditorial

4 Citations (Scopus)

Abstract

This themed issue on molecular medicine and cancer explores the impact of chemistry on recent developments in cancer therapy and the prospects for future step-changes, in particular new approaches to targeted/personalized therapies, chemoprevention and the emergence of drug discovery in academia. Clinical success stories are highlighted as well as selected examples of novel compounds in development.
Original languageEnglish
Pages (from-to)8771-8772
Number of pages2
JournalChemical Society Reviews
Volume44
Issue number24
Early online date23 Nov 2015
DOIs
Publication statusPublished - 21 Dec 2015

Fingerprint

Medicine
Drug Discovery
Chemoprevention

Keywords

  • Antineoplastic Agents
  • Humans
  • Molecular Medicine
  • Neoplasms

Cite this

Wallace, H. M., Hergenrother, P. J., & Sadler, P. J. (2015). Molecular medicine and cancer. Chemical Society Reviews, 44(24), 8771-8772. https://doi.org/10.1039/c5cs90123e

Molecular medicine and cancer. / Wallace, Heather M; Hergenrother, Paul J; Sadler, Peter J.

In: Chemical Society Reviews, Vol. 44, No. 24, 21.12.2015, p. 8771-8772.

Research output: Contribution to journalEditorial

Wallace, HM, Hergenrother, PJ & Sadler, PJ 2015, 'Molecular medicine and cancer', Chemical Society Reviews, vol. 44, no. 24, pp. 8771-8772. https://doi.org/10.1039/c5cs90123e
Wallace, Heather M ; Hergenrother, Paul J ; Sadler, Peter J. / Molecular medicine and cancer. In: Chemical Society Reviews. 2015 ; Vol. 44, No. 24. pp. 8771-8772.
@article{70f3e9d60ccb49f192d2acda1c4d14ff,
title = "Molecular medicine and cancer",
abstract = "This themed issue on molecular medicine and cancer explores the impact of chemistry on recent developments in cancer therapy and the prospects for future step-changes, in particular new approaches to targeted/personalized therapies, chemoprevention and the emergence of drug discovery in academia. Clinical success stories are highlighted as well as selected examples of novel compounds in development.",
keywords = "Antineoplastic Agents, Humans, Molecular Medicine, Neoplasms",
author = "Wallace, {Heather M} and Hergenrother, {Paul J} and Sadler, {Peter J}",
year = "2015",
month = "12",
day = "21",
doi = "10.1039/c5cs90123e",
language = "English",
volume = "44",
pages = "8771--8772",
journal = "Chemical Society Reviews",
issn = "0306-0012",
publisher = "Royal Society of Chemistry",
number = "24",

}

TY - JOUR

T1 - Molecular medicine and cancer

AU - Wallace, Heather M

AU - Hergenrother, Paul J

AU - Sadler, Peter J

PY - 2015/12/21

Y1 - 2015/12/21

N2 - This themed issue on molecular medicine and cancer explores the impact of chemistry on recent developments in cancer therapy and the prospects for future step-changes, in particular new approaches to targeted/personalized therapies, chemoprevention and the emergence of drug discovery in academia. Clinical success stories are highlighted as well as selected examples of novel compounds in development.

AB - This themed issue on molecular medicine and cancer explores the impact of chemistry on recent developments in cancer therapy and the prospects for future step-changes, in particular new approaches to targeted/personalized therapies, chemoprevention and the emergence of drug discovery in academia. Clinical success stories are highlighted as well as selected examples of novel compounds in development.

KW - Antineoplastic Agents

KW - Humans

KW - Molecular Medicine

KW - Neoplasms

U2 - 10.1039/c5cs90123e

DO - 10.1039/c5cs90123e

M3 - Editorial

VL - 44

SP - 8771

EP - 8772

JO - Chemical Society Reviews

JF - Chemical Society Reviews

SN - 0306-0012

IS - 24

ER -